Literature DB >> 26829052

Eukaryotic initiation factor 4E-binding protein 1 (4E-BP1): a master regulator of mRNA translation involved in tumorigenesis.

J Musa1, M F Orth1, M Dallmayer1, M Baldauf1, C Pardo2, B Rotblat2, T Kirchner3,4,5, G Leprivier2,6, T G P Grünewald1.   

Abstract

Protein synthesis activity is abnormally enhanced in cancer cells to support their uncontrolled growth. However, this process needs to be tightly restricted under metabolic stress-a condition often found within the tumor microenvironment-to preserve cell viability. mTORC1 is critical to link protein synthesis activity to nutrient and oxygen levels, in part by controlling the 4E-BP1-eIF4E axis. Whereas mTORC1 and eIF4E are known pro-tumorigenic factors, whose expression or activity is increased in numerous cancers, the role of 4E-BP1 in cancer is not yet definitive. On the one hand, 4E-BP1 has tumor suppressor activity by inhibiting eIF4E and, thus, blocking mRNA translation and proliferation. This is corroborated by elevated levels of phosphorylated and hence inactive 4E-BP1, which are detected in various cancers. On the other hand, 4E-BP1 has pro-tumorigenic functions as it promotes tumor adaptation to metabolic and genotoxic stress by selectively enhancing or preventing the translation of specific transcripts. Here we describe the molecular and cellular functions of 4E-BP1 and highlight the distinct roles of 4E-BP1 in cancer depending on the microenvironmental context of the tumor.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26829052     DOI: 10.1038/onc.2015.515

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  178 in total

Review 1.  Targeting the PI3K-Akt pathway in human cancer: rationale and promise.

Authors:  Ji Luo; Brendan D Manning; Lewis C Cantley
Journal:  Cancer Cell       Date:  2003-10       Impact factor: 31.743

2.  Expression of the translation initiation factor eIF4E in the polyp-cancer sequence in the colon.

Authors:  H J Berkel; E A Turbat-Herrera; R Shi; A de Benedetti
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2001-06       Impact factor: 4.254

3.  Validation of mammalian target of rapamycin biomarker panel in patients with clear cell renal cell carcinoma.

Authors:  Ahmed Q Haddad; Payal Kapur; Nirmish Singla; Jay D Raman; Matthew T Then; Philipp Nuhn; Alexander Buchner; Patrick Bastian; Christian Seitz; Shahrokh F Shariat; Karim Bensalah; Nathalie Rioux-Leclercq; Arthur Sagalowsky; Yair Lotan; Vitaly Margulis
Journal:  Cancer       Date:  2014-09-03       Impact factor: 6.860

4.  Caspase cleavage of initiation factor 4E-binding protein 1 yields a dominant inhibitor of cap-dependent translation and reveals a novel regulatory motif.

Authors:  Andrew R Tee; Christopher G Proud
Journal:  Mol Cell Biol       Date:  2002-03       Impact factor: 4.272

5.  PTEN promoter methylation and activation of the PI3K/Akt/mTOR pathway in pediatric gliomas and influence on clinical outcome.

Authors:  Sabine Mueller; Joanna Phillips; Arzu Onar-Thomas; Eloy Romero; Shichun Zheng; John K Wiencke; Sean M McBride; Cynthia Cowdrey; Michael D Prados; William A Weiss; Mitchel S Berger; Nalin Gupta; Daphne A Haas-Kogan
Journal:  Neuro Oncol       Date:  2012-06-29       Impact factor: 12.300

6.  Activation of the mammalian target of rapamycin signalling pathway in epidermal tumours and its correlation with cyclin-dependent kinase 2.

Authors:  S-J Chen; T Nakahara; M Takahara; M Kido; L Dugu; H Uchi; S Takeuchi; Y-T Tu; Y Moroi; M Furue
Journal:  Br J Dermatol       Date:  2008-10-25       Impact factor: 9.302

7.  Regulation of mTORC1 and mTORC2 complex assembly by phosphatidic acid: competition with rapamycin.

Authors:  Alfredo Toschi; Evan Lee; Limei Xu; Avalon Garcia; Noga Gadir; David A Foster
Journal:  Mol Cell Biol       Date:  2008-12-29       Impact factor: 4.272

8.  Expression of eukaryotic translation initiation factors 4E and 2alpha correlates with the progression of thyroid carcinoma.

Authors:  S Wang; R V Lloyd; M J Hutzler; I B Rosenwald; M S Safran; N A Patwardhan; A Khan
Journal:  Thyroid       Date:  2001-12       Impact factor: 6.568

9.  Phosphorylated 4E-binding protein 1 expression is associated with poor prognosis in small-cell lung cancer.

Authors:  Mee Sook Roh; Ji Hyun Lee; Kyung Woo Kang; Hyun-Yeol Nam; Sang Bong Jung; Kyungeun Kim; Eun Hee Lee; Moon-Il Park; Mee-Seon Kim; Hyoun Wook Lee
Journal:  Virchows Arch       Date:  2015-10-07       Impact factor: 4.064

10.  Inhibition of 4E-BP1 sensitizes U87 glioblastoma xenograft tumors to irradiation by decreasing hypoxia tolerance.

Authors:  Ludwig Dubois; Michaël G Magagnin; Arjen H G Cleven; Sherry A Weppler; Beat Grenacher; Willy Landuyt; Natasja Lieuwes; Philippe Lambin; Thomas A Gorr; Marianne Koritzinsky; Bradly G Wouters
Journal:  Int J Radiat Oncol Biol Phys       Date:  2009-03-15       Impact factor: 7.038

View more
  49 in total

1.  mTOR inhibitors for treatment of low-risk prostate cancer.

Authors:  Michael A Liss; Lanette Rickborn; John DiGiovanni; Dean Bacich; Linda A DeGraffenried; Manish Parihar; Ian M Thompson; Zelton Dave Sharp
Journal:  Med Hypotheses       Date:  2018-06-05       Impact factor: 1.538

2.  Mitotic protein kinase CDK1 phosphorylation of mRNA translation regulator 4E-BP1 Ser83 may contribute to cell transformation.

Authors:  Celestino Velásquez; Erdong Cheng; Masahiro Shuda; Paula J Lee-Oesterreich; Lisa Pogge von Strandmann; Marina A Gritsenko; Jon M Jacobs; Patrick S Moore; Yuan Chang
Journal:  Proc Natl Acad Sci U S A       Date:  2016-07-11       Impact factor: 11.205

3.  Sauchinone: a prospective therapeutic agent-mediated EIF4EBP1 down-regulation suppresses proliferation, invasion and migration of lung adenocarcinoma cells.

Authors:  Sheng-Qian Li; Jing Feng; Ming Yang; Xiao-Peng Ai; Mei He; Fu Liu
Journal:  J Nat Med       Date:  2020-07-15       Impact factor: 2.343

4.  A new mechanism for translational control in plants.

Authors:  W Allen Miller; Savithramma P Dinesh-Kumar
Journal:  FEBS J       Date:  2019-08-09       Impact factor: 5.542

5.  Expression of upstream and downstream targets of mTOR pathway in seven cases of secretory carcinoma of salivary gland origin.

Authors:  Marcos Custódio; Bruno Tavares Sedassari; Albina Altemani; Maria Fernanda Setúbal Destro Rodrigues; Fábio Daumas Nunes; Suzana Cantanhede Orsini Machado de Sousa
Journal:  Eur Arch Otorhinolaryngol       Date:  2020-06-23       Impact factor: 2.503

6.  A Yeast System for Discovering Optogenetic Inhibitors of Eukaryotic Translation Initiation.

Authors:  Huixin Lu; Mostafizur Mazumder; Anna S I Jaikaran; Anil Kumar; Eric K Leis; Xiuling Xu; Michael Altmann; Alan Cochrane; G Andrew Woolley
Journal:  ACS Synth Biol       Date:  2019-04-04       Impact factor: 5.110

7.  mTORC1/2 and Protein Translation Regulate Levels of CHK1 and the Sensitivity to CHK1 Inhibitors in Ewing Sarcoma Cells.

Authors:  Stacia L Koppenhafer; Kelli L Goss; William W Terry; David J Gordon
Journal:  Mol Cancer Ther       Date:  2018-10-03       Impact factor: 6.261

8.  Eukaryotic initiation factor 4E is a novel effector of mTORC1 signaling pathway in cross talk with Mnk1.

Authors:  Asiya Batool; Sheikh Tahir Majeed; Sabreena Aashaq; Rabiya Majeed; Nadiem Nazir Bhat; Khurshid Iqbal Andrabi
Journal:  Mol Cell Biochem       Date:  2019-11-28       Impact factor: 3.396

Review 9.  Reading m6A in the Transcriptome: m6A-Binding Proteins.

Authors:  Deepak P Patil; Brian F Pickering; Samie R Jaffrey
Journal:  Trends Cell Biol       Date:  2017-11-02       Impact factor: 20.808

Review 10.  Pharmacological Manipulation of Translation as a Therapeutic Target for Chronic Pain.

Authors:  Muhammad Saad Yousuf; Stephanie I Shiers; James J Sahn; Theodore J Price
Journal:  Pharmacol Rev       Date:  2021-01       Impact factor: 25.468

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.